4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001062993-22-015188
Options or other derivatives
- Director acquired 86,467 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ALTMAN MICHAEL SETH · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-15 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +86,467 | 86,467 | D |
Loading xslF345X03/form4.xml…